" /> Allogeneic Anti-CD19 CAR-gamma/delta T-cells QH103 - CISMeF





Preferred Label : Allogeneic Anti-CD19 CAR-gamma/delta T-cells QH103;

NCIt synonyms : Allogeneic Anti-CD19 CAR-gamma-delta T Cells QH103; Allogeneic CD19 CAR-gamma Delta T Cells QH103; Allogeneic Anti-CD19 CAR Gamma Delta T-cells QH103; Allogeneic Anti-CD19 CAR Gamma Delta T Cells QH103; Allogeneic CD19 CAR-gdT-cells QH103;

NCIt definition : A preparation of a subset of allogeneic T-lymphocytes that express only gamma chain and delta chain T-cell receptors (TCRs) and that are engineered to express a chimeric antigen receptor (CAR) targeting the tumor-associated antigen (TAA) CD19, with potential immunomodulating and antineoplastic activities. Upon administration, allogeneic anti-CD19 CAR-gamma/delta T-cells QH103 target and bind to CD19-expressing tumor cells, thereby inducing selective toxicity in CD19-expressing tumor cells. Gamma/delta T-lymphocytes play a key role in the activation of the immune system and do not require major histocompatibility complex (MHC)-mediated antigen presentation to exert their cytotoxic effect. CD19 is overexpressed on certain tumor cell types.;

Molecule name : QH 103; QH-103;

NCI Metathesaurus CUI : CL1921225;

Détails


Vous pouvez consulter :


Nous contacter.
29/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.